{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T18:37:44Z","timestamp":1783535864910,"version":"3.55.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T00:00:00Z","timestamp":1639785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.dld.2021.12.007","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T02:58:46Z","timestamp":1641783526000},"page":"1007-1014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Current treatment options of refractory ascites in liver cirrhosis \u2013 A systematic review and meta-analysis"],"prefix":"10.1016","volume":"54","author":[{"given":"Valerie","family":"Will","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana G.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4562-9016","authenticated-orcid":false,"given":"Annalisa","family":"Berzigotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2021.12.007_bib0001","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1177\/0300060517735231","article-title":"Current management of refractory ascites in patients with cirrhosis","volume":"46","author":"Zhao","year":"2018","journal-title":"J Int Med Res"},{"key":"10.1016\/j.dld.2021.12.007_bib0002","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/hep.24786","article-title":"Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials","volume":"55","author":"Bernardi","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.12.007_bib0003","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3748\/wjg.v20.i10.2704","article-title":"TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis","volume":"20","author":"Bai","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2021.12.007_bib0004","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jhep.2005.06.005","article-title":"A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites","volume":"43","author":"Albillos","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.12.007_bib0005","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1478-3231.2005.01095.x","article-title":"Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis","volume":"25","author":"Deltenre","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2021.12.007_bib0006","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1053\/j.gastro.2005.07.031","article-title":"Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis","volume":"129","author":"D'Amico","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2021.12.007_bib0007","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1053\/j.gastro.2007.06.020","article-title":"Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data","volume":"133","author":"Salerno","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2021.12.007_bib0008","first-page":"1","article-title":"Systematic review with meta - analysis\u00a0: automated low - flow ascites pump therapy for refractory ascites","volume":"00","author":"Lepida","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2021.12.007_bib0009","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.sla.0000128309.36393.71","article-title":"TIPS versus peritoneovenous shunt in the treatment of medically intractable ascites: a prospective randomized trial","volume":"239","author":"Rosemurgy","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.dld.2021.12.007_bib0010","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/liv.14162","article-title":"Permanent indwelling peritoneal catheters for palliation of refractory ascites in end-stage liver disease: a systematic review","volume":"39","author":"Macken","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2021.12.007_bib0011","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/08998280.2018.1461525","article-title":"Chronic peritoneal indwelling catheters for the management of malignant and nonmalignant ascites","volume":"31","author":"Caldwell","year":"2018","journal-title":"Baylor Univ Med Cent Proc"},{"key":"10.1016\/j.dld.2021.12.007_bib0012","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"Angeli","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.12.007_bib0013","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2147\/HMER.S136578","article-title":"Management of refractory cirrhotic ascites: challenges and solutions","volume":"10","author":"Fukui","year":"2018","journal-title":"Hepatic Med Evid Res"},{"key":"10.1016\/j.dld.2021.12.007_bib0014","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1177\/2050640620938525","article-title":"Transjugular intrahepatic portosystemic shunt and alfapump\u00ae system for refractory ascites in liver cirrhosis: outcomes and complications","volume":"8","author":"Will","year":"2020","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.dld.2021.12.007_bib0015","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in Epidemiology","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.dld.2021.12.007_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.dld.2021.12.007_bib0017","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1177\/1049732312452938","article-title":"Beyond PICO: the SPIDER tool for qualitative evidence synthesis","volume":"22","author":"Cooke","year":"2012","journal-title":"Qual Health Res"},{"key":"10.1016\/j.dld.2021.12.007_bib0018","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.dld.2021.12.007_bib0019","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00270-018-2040-y","article-title":"Transjugular intrahepatic portosystemic shunt using the new gore viatorr controlled expansion endoprosthesis: prospective, single-center, preliminary experience","volume":"42","author":"Miraglia","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.dld.2021.12.007_bib0020","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1016\/j.cgh.2019.03.042","article-title":"Smaller-diameter covered transjugular intrahepatic portosystemic shunt stents are associated with increased survival","volume":"17","author":"Trebicka","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.12.007_bib0021","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1148\/radiol.2017161644","article-title":"Transjugular intrahepatic portosystemic shunts in cirrhosis with refractory ascites: comparison of clinical outcomes by using 8- and 10-mm PTFE-covered stents","volume":"284","author":"Miraglia","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.dld.2021.12.007_bib0022","first-page":"1","article-title":"Primary constrained TIPS for treating refractory ascites or variceal bleeding secondary to hepatic cirrhosis","volume":"90","author":"Rabei","year":"2017","journal-title":"Br J Radiol"},{"key":"10.1016\/j.dld.2021.12.007_bib0023","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2016-312388.509","article-title":"PTH-105 introduction of transjugular intrahepatic portosystemic shunt (TIPSS) service for refractory ascites in a non-transplant liver unit","volume":"65","author":"Saleem","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.dld.2021.12.007_bib0024","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MCG.0000000000000339","article-title":"A standardized assessment of functional disability predicts 1-year mortality in patients undergoing transjugular intrahepatic portosystemic shunt for refractory ascites","volume":"50","author":"Grunwald","year":"2016","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2021.12.007_bib0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jgh.12725","article-title":"Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion","volume":"30","author":"Tan","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.12.007_bib0026","doi-asserted-by":"crossref","first-page":"654","DOI":"10.2214\/AJR.14.12885","article-title":"TIPS for refractory ascites: a 6-year single-center experience with expanded polytetrafluoroethylene-covered stent-grafts","volume":"204","author":"Bercu","year":"2015","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.dld.2021.12.007_bib0027","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.crad.2015.02.002","article-title":"Survival benefit of TIPS versus serial paracentesis in patients with refractory ascites: a single institution case-control propensity score analysis","volume":"70","author":"Gaba","year":"2015","journal-title":"Clin Radiol"},{"key":"10.1016\/j.dld.2021.12.007_bib0028","first-page":"58","article-title":"Transjugular intrahepatic portosystemic shunt for the treatment of medically refractory ascites","volume":"20","author":"Parvinian","year":"2014","journal-title":"Diagn Interv Radiol"},{"key":"10.1016\/j.dld.2021.12.007_bib0029","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/hepr.12195","article-title":"Predictive factors for improvement of ascites after transjugular intrahepatic portosystemic shunt in patients with refractory ascites","volume":"44","author":"Taki","year":"2014","journal-title":"Hepatol Res"},{"key":"10.1016\/j.dld.2021.12.007_bib0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3350\/cmh.2014.20.1.18","article-title":"Clinical outcomes of transjugular intrahepatic portosystemic shunt for portal hypertension: Korean multicenter real-practice data","volume":"20","author":"Kim","year":"2014","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.dld.2021.12.007_bib0031","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/MEG.0000000000001342","article-title":"Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis","volume":"31","author":"Dissegna","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.12.007_bib0032","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.dld.2014.06.013","article-title":"Prognostic factors in patients with refractory ascites treated by transjugular intrahepatic porto-systemic shunt: from the liver to the kidney","volume":"46","author":"Hamel","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2021.12.007_bib0033","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/flgastro-2012-100283","article-title":"Trans-jugular intrahepatic porto-systemic shunt placement for refractory ascites: a \u2018real-world\u2019 UK health economic evaluation","volume":"4","author":"Parker","year":"2013","journal-title":"Frontline Gastroenterol"},{"key":"10.1016\/j.dld.2021.12.007_bib0034","first-page":"5211","article-title":"Clinical outcome and predictors of survival after TIPS insertion in patients with liver cirrhosis","volume":"18","author":"Heinzow","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2021.12.007_bib0035","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.3109\/00365521.2012.703239","article-title":"Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience","volume":"47","author":"Lodato","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dld.2021.12.007_bib0036","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2010.02.033","article-title":"Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial","volume":"53","author":"Riggio","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.12.007_bib0037","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.RVI.0000240651.38289.4B","article-title":"Predictors of early mortality after transjugular intrahepatic portosystemic shunt creation for the treatment of refractory ascites","volume":"17","author":"Harrod-Kim","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.dld.2021.12.007_bib0038","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1440-1746.2005.03601.x","article-title":"Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed","volume":"20","author":"Membreno","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.12.007_bib0039","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1007\/s00330-004-2359-4","article-title":"Early and long-term clinical and radiological follow-up results of expanded-polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunt procedures","volume":"14","author":"Maleux","year":"2004","journal-title":"Eur Radiol"},{"key":"10.1016\/j.dld.2021.12.007_bib0040","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00042737-200406000-00015","article-title":"Application of the model for end-stage liver disease score for transjugular intrahepatic portosystemic shunt in cirrhotic patients with refractory ascites and renal impairment","volume":"16","author":"Alessandria","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.12.007_bib0041","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/hep.20364","article-title":"Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites","volume":"40","author":"Salerno","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.12.007_bib0042","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.diii.2018.10.006","article-title":"Transjugular intrahepatic portosystemic shunt (TIPS) placement: a comparison of outcomes between patients with hepatic hydrothorax and patients with refractory ascites","volume":"100","author":"Young","year":"2019","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.dld.2021.12.007_bib0043","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1148\/radiol.2311030967","article-title":"Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score","volume":"231","author":"Ferral","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.dld.2021.12.007_bib0044","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1148\/radiol.2312021797","article-title":"Transjugular intrahepatic portosystemic shunts: long-term patency and clinical results in a patient cohort observed for 3-9 years","volume":"231","author":"Ter Borg","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.dld.2021.12.007_bib0045","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1023\/A:1022544917898","article-title":"Tips for management of refractory ascites: response and survival are both unpredictable","volume":"48","author":"Thuluvath","year":"2003","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2021.12.007_bib0046","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1053\/gast.2003.50088","article-title":"The North American study for the treatment of refractory ascites","volume":"124","author":"Sanyal","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2021.12.007_bib0047","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1053\/jlts.2002.31653","article-title":"Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt","volume":"8","author":"Russo","year":"2002","journal-title":"Liver Transplant"},{"key":"10.1016\/j.dld.2021.12.007_bib0048","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/gast.2002.37073","article-title":"Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis","volume":"123","author":"Gin\u00e8s","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2021.12.007_bib0049","first-page":"154","article-title":"Transjugular intrahepatic portosystemic shunt in the treatment of refractory ascites","volume":"55","author":"Niangova","year":"2001","journal-title":"Ces Radiol"},{"key":"10.1016\/j.dld.2021.12.007_bib0050","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1056\/NEJM200006083422303","article-title":"A comparison of paracnetesis and transjugular intrahepatic portosystemic shunting in patients with ascites","volume":"342","author":"R\u00f6ssle","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2021.12.007_bib0051","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1572-0241.1999.01112.x","article-title":"Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites","volume":"94","author":"Desch\u00eanes","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2021.12.007_bib0052","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1445-5994.1998.tb00658.x","article-title":"Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of refractory ascites","volume":"28","author":"Williams","year":"1998","journal-title":"Aust NZ J Med"},{"key":"10.1016\/j.dld.2021.12.007_bib0053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-018-1067-7","article-title":"Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment","volume":"15","author":"Teng","year":"2018","journal-title":"Virol J"},{"key":"10.1016\/j.dld.2021.12.007_bib0054","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1055\/s-2007-1015143","article-title":"TIPSS: technische und klinische Ergebnisse nach 4 Jahren. RoFo Fortschritte auf dem Gebiete der Rontgenstrahlen und der","volume":"168","author":"Textor","year":"1998","journal-title":"Neuen Bildgeb Verfahren"},{"key":"10.1016\/j.dld.2021.12.007_bib0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1018861827399","article-title":"Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS). A caution","volume":"42","author":"Martinet","year":"1997","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2021.12.007_bib0056","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1148\/radiology.205.1.9314981","article-title":"Refractory ascites: midterm results of treatment with a transjugular intrahepatic portosystemic shunt","volume":"205","author":"Nazarian","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.dld.2021.12.007_bib0057","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1148\/radiology.200.1.8657908","article-title":"Severe ascites: efficacy of the transjugular intrahepatic portosystemic shunt in treatment","volume":"200","author":"Crenshaw","year":"1996","journal-title":"Radiology"},{"key":"10.1016\/j.dld.2021.12.007_bib0058","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-8278(96)80065-1","article-title":"Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial","volume":"25","author":"Lebrec","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.12.007_bib0059","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1365-2036.1996.60202000.x","article-title":"Clinical response after transjugular intrahepatic portosystemic stent shunt insertion for refractory ascites","volume":"10","author":"Forrest","year":"1996","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2021.12.007_bib0060","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1148\/radiology.189.3.8234706","article-title":"Refractory ascites: early experience in treatment with transjugular intrahepatic portosystemic shunt","volume":"189","author":"Ferral","year":"1993","journal-title":"Radiology"},{"key":"10.1016\/j.dld.2021.12.007_bib0061","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1016\/j.jvir.2018.01.657","article-title":"Abstract No. 612 outcomes of transjugular intrahepatic portosystemic shunt using 12-mm-diameter polytetrafluoroethylene-covered stents in cirrhotic patients with portal hypertension and refractory ascites","volume":"29","author":"Gunn","year":"2018","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.dld.2021.12.007_bib0062","doi-asserted-by":"crossref","first-page":"S735","DOI":"10.1016\/S0168-8278(18)31732-X","article-title":"Transjugular intrahepatic portosystemic shunt is highly effective in patients with a MELD score <20 and does not require routine Doppler ultrasound follow-up","volume":"68","author":"de Wit","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.12.007_bib0063","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2214\/AJR.17.18222","article-title":"Incrementally expandable transjugular intrahepatic portosystemic shunts: single-center experience","volume":"210","author":"Cui","year":"2018","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.dld.2021.12.007_bib0064","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/liv.13615","article-title":"ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis","volume":"38","author":"Bucsics","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2021.12.007_bib0065","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.gastro.2016.09.016","article-title":"Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites","volume":"152","author":"Bureau","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2021.12.007_bib0066","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/MEG.0000000000001149","article-title":"Automated low-flow ascites pump in a real-world setting: complications and outcomes","volume":"30","author":"Solbach","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.12.007_bib0067","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/apt.14331","article-title":"Treatment of refractory ascites with an automated low-flow ascites pump in patients with cirrhosis","volume":"46","author":"Stirnimann","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2021.12.007_bib0068","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/lt.24763","article-title":"Effects of alfapump\u2122 system on kidney and circulatory function in patients with cirrhosis and refractory ascites","volume":"23","author":"Sol\u00e0","year":"2017","journal-title":"Liver Transplant"},{"key":"10.1016\/j.dld.2021.12.007_bib0069","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00423-015-1356-1","article-title":"Automated low flow pump system for the treatment of refractory ascites: a single-center experience. Langenbeck's","volume":"400","author":"Thomas","year":"2015","journal-title":"Arch Surg"},{"key":"10.1016\/j.dld.2021.12.007_bib0070","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jhep.2012.12.020","article-title":"Automated low flow pump system for the treatment of refractory ascites: a multi-center safety and efficacy study","volume":"58","author":"Bellot","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.12.007_bib0071","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2017.06.010","article-title":"Alfapump\u00ae system vs. large volume paracentesis for refractory ascites: a multicenter randomized controlled study","volume":"67","author":"Bureau","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.12.007_bib0072","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.transproceed.2018.04.089","article-title":"Use of peritoneovenous shunt for the management of refractory ascites","volume":"51","author":"Ayll\u00f3n","year":"2019","journal-title":"Transplant Proc"},{"key":"10.1016\/j.dld.2021.12.007_bib0073","doi-asserted-by":"crossref","first-page":"S786","DOI":"10.1016\/j.hpb.2018.06.2376","article-title":"Use of peritoneovenous shunts in patients with intractable ascites in the era of liver transplantation","volume":"20","author":"Cassar","year":"2018","journal-title":"HPB"},{"key":"10.1016\/j.dld.2021.12.007_bib0074","first-page":"124","article-title":"Treatment of patients with cirrhosis and refractory ascites using LeVeen shunt with titanium tip: comparison with therapeutic paracentesis","volume":"22","author":"Gines","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.12.007_bib0075","first-page":"373","article-title":"Peritoneovenous shunting of intractable ascites in patients with cirrhosis: improving results and predictive factors of failure","volume":"113","author":"Hillaire","year":"1993","journal-title":"Surgery"},{"key":"10.1016\/j.dld.2021.12.007_bib0076","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJM199109193251201","article-title":"Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites","volume":"325","author":"Gin\u00e8s","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2021.12.007_bib0077","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/00000658-198504000-00014","article-title":"The LeVeen shunt in the elective treatment of intractable ascites in cirrhosis","volume":"201","author":"Smadja","year":"1985","journal-title":"Ann Surg"},{"key":"10.1016\/j.dld.2021.12.007_bib0078","first-page":"1","article-title":"The influence of a peritoneovenous shunt for cirrhotic and malignant intractable ascites on renal function","volume":"7","author":"Segawa","year":"2018","journal-title":"Acta Radiol Open"},{"key":"10.1016\/j.dld.2021.12.007_bib0079","first-page":"3668","article-title":"Percutaneous implant of Denver peritoneovenous shunt for treatment of refractory ascites: a single center retrospective study","volume":"21","author":"Piccirillo","year":"2017","journal-title":"Eur Rev Med Pharmalogical Sci"},{"key":"10.1016\/j.dld.2021.12.007_bib0080","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.jvir.2008.09.005","article-title":"Percutaneous peritoneovenous shunt for treatment of refractory ascites","volume":"19","author":"Won","year":"2008","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.dld.2021.12.007_bib0081","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1111\/j.1600-6143.2005.00959.x","article-title":"Peritoneovenous shunt as a bridge to liver transplantation","volume":"5","author":"Dumortier","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.dld.2021.12.007_bib0082","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1445-2197.2005.03315.x","article-title":"Modified saphenous-peritoneal shunt in refractory ascites: new technique","volume":"75","author":"Chen","year":"2005","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.dld.2021.12.007_bib0083","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0002-9610(00)00565-1","article-title":"Saphenoperitoneal anastomosis for resistant ascites in patients with cirrhosis","volume":"181","author":"Deen","year":"2001","journal-title":"Am J Surg"},{"key":"10.1016\/j.dld.2021.12.007_bib0084","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1046\/j.1365-2168.1999.01156.x","article-title":"Saphenoperitoneal shunts for patients with intractable ascites associated with chronic liver disease","volume":"86","author":"Vadeyar","year":"1999","journal-title":"Br J Surg"},{"key":"10.1016\/j.dld.2021.12.007_bib0085","first-page":"157","article-title":"Peritoneovenous shunts in patients with intractable ascites: palliation at what price?","volume":"63","author":"Zervos","year":"1997","journal-title":"Am Surg"},{"key":"10.1016\/j.dld.2021.12.007_bib0086","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1177\/0269216316671281","article-title":"Palliative long-term abdominal drains in refractory ascites due to end-stage liver disease: a case series","volume":"31","author":"Macken","year":"2017","journal-title":"Palliat Med"},{"key":"10.1016\/j.dld.2021.12.007_bib0087","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/MEG.0000000000000837","article-title":"Home-based drainage of refractory ascites by a permanent-tunneled peritoneal catheter can safely replace large-volume paracentesis","volume":"29","author":"Solbach","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.12.007_bib0088","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4680543","article-title":"The palliative management of refractory cirrhotic ascites using the PleurX\u00a9 catheter","author":"Reinglas","year":"2016","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.12.007_bib0089","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.14309\/00000434-201210001-00349","article-title":"The safety and efficacy of tunneled, indwelling peritoneal catheter drainage for refractory, non-malignant ascites","volume":"107","author":"Kundu","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2021.12.007_bib0090","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/imj.12843","article-title":"Indwelling peritoneal catheters in patients with cirrhosis and refractory ascites","volume":"45","author":"Kathpalia","year":"2015","journal-title":"Intern Med J"},{"key":"10.1016\/j.dld.2021.12.007_bib0091","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.25011\/cim.v39i6.27502","article-title":"High dose oral furosemide with salt ingestion in the treatment of refractory ascites of liver cirrhosis","volume":"39","author":"Yakar","year":"2016","journal-title":"Clin Investig Med"},{"key":"10.1016\/j.dld.2021.12.007_bib0092","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0165443","article-title":"Immune-inflammatory and metabolic effects of high dose furosemide plus hypertonic saline solution (HSS) treatment in cirrhotic subjects with refractory ascites","volume":"11","author":"Tuttolomondo","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2021.12.007_bib0093","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1007\/s10620-016-4140-3","article-title":"Albumin may prevent the morbidity of paracentesis-induced circulatory dysfunction in cirrhosis and refractory ascites: a pilot study","volume":"61","author":"Tan","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2021.12.007_bib0094","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-2001-10707","article-title":"Prospective study comparing human albumin vs. reinfusion of ultrafiltrate-ascitic fluid after total paracentesis in cirrhotic patients with tense ascites","volume":"39","author":"Zaak","year":"2001","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.dld.2021.12.007_bib0095","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cgh.2011.08.028","article-title":"Muscle wasting is associated with mortality in patients with cirrhosis","volume":"10","author":"Montano-Loza","year":"2012","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086582100894X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086582100894X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:20:27Z","timestamp":1761625227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S159086582100894X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":95,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S159086582100894X"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2021.12.007","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current treatment options of refractory ascites in liver cirrhosis \u2013 A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2021.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}